197 related articles for article (PubMed ID: 37610619)
1. Active Uptake of Oxycodone at Both the Blood-Cerebrospinal Fluid Barrier and The Blood-Brain Barrier without Sex Differences: A Rat Microdialysis Study.
Bällgren F; Hammarlund-Udenaes M; Loryan I
Pharm Res; 2023 Nov; 40(11):2715-2730. PubMed ID: 37610619
[TBL] [Abstract][Full Text] [Related]
2. In vivo blood-brain barrier transport of oxycodone in the rat: indications for active influx and implications for pharmacokinetics/pharmacodynamics.
Boström E; Simonsson US; Hammarlund-Udenaes M
Drug Metab Dispos; 2006 Sep; 34(9):1624-31. PubMed ID: 16763013
[TBL] [Abstract][Full Text] [Related]
3. Investigation of utility of cerebrospinal fluid drug concentration as a surrogate for interstitial fluid concentration using microdialysis coupled with cisternal cerebrospinal fluid sampling in wild-type and Mdr1a(-/-) rats.
Nagaya Y; Nozaki Y; Takenaka O; Watari R; Kusano K; Yoshimura T; Kusuhara H
Drug Metab Pharmacokinet; 2016 Feb; 31(1):57-66. PubMed ID: 26830080
[TBL] [Abstract][Full Text] [Related]
4. Cocktail-Dosing Microdialysis Study to Simultaneously Assess Delivery of Multiple Organic-Cationic Drugs to the Brain.
Kitamura A; Okura T; Higuchi K; Deguchi Y
J Pharm Sci; 2016 Feb; 105(2):935-940. PubMed ID: 26554532
[TBL] [Abstract][Full Text] [Related]
5. [The blood-brain barrier transport mechanism controlling analgesic effects of opioid drugs in CNS].
Okura T; Higuchi K; Deguchi Y
Yakugaku Zasshi; 2015; 135(5):697-702. PubMed ID: 25948304
[TBL] [Abstract][Full Text] [Related]
6. Blood-brain barrier transport helps to explain discrepancies in in vivo potency between oxycodone and morphine.
Boström E; Hammarlund-Udenaes M; Simonsson US
Anesthesiology; 2008 Mar; 108(3):495-505. PubMed ID: 18292687
[TBL] [Abstract][Full Text] [Related]
7. Quantitative investigation of the brain-to-cerebrospinal fluid unbound drug concentration ratio under steady-state conditions in rats using a pharmacokinetic model and scaling factors for active efflux transporters.
Kodaira H; Kusuhara H; Fuse E; Ushiki J; Sugiyama Y
Drug Metab Dispos; 2014 Jun; 42(6):983-9. PubMed ID: 24644297
[TBL] [Abstract][Full Text] [Related]
8. Combined PET and microdialysis for in vivo estimation of drug blood-brain barrier transport and brain unbound concentrations.
Gustafsson S; Eriksson J; Syvänen S; Eriksson O; Hammarlund-Udenaes M; Antoni G
Neuroimage; 2017 Jul; 155():177-186. PubMed ID: 28467891
[TBL] [Abstract][Full Text] [Related]
9. Diphenhydramine active uptake at the blood-brain barrier and its interaction with oxycodone in vitro and in vivo.
Sadiq MW; Borgs A; Okura T; Shimomura K; Kato S; Deguchi Y; Jansson B; Björkman S; Terasaki T; Hammarlund-Udenaes M
J Pharm Sci; 2011 Sep; 100(9):3912-23. PubMed ID: 21472729
[TBL] [Abstract][Full Text] [Related]
10. In Vivo Quantitative Understanding of PEGylated Liposome's Influence on Brain Delivery of Diphenhydramine.
Hu Y; Gaillard PJ; Rip J; de Lange ECM; Hammarlund-Udenaes M
Mol Pharm; 2018 Dec; 15(12):5493-5500. PubMed ID: 30376346
[TBL] [Abstract][Full Text] [Related]
11. Transport characteristics of tramadol in the blood-brain barrier.
Kitamura A; Higuchi K; Okura T; Deguchi Y
J Pharm Sci; 2014 Oct; 103(10):3335-41. PubMed ID: 25175482
[TBL] [Abstract][Full Text] [Related]
12. Quantification of Transporter and Receptor Proteins in Dog Brain Capillaries and Choroid Plexus: Relevance for the Distribution in Brain and CSF of Selected BCRP and P-gp Substrates.
Braun C; Sakamoto A; Fuchs H; Ishiguro N; Suzuki S; Cui Y; Klinder K; Watanabe M; Terasaki T; Sauer A
Mol Pharm; 2017 Oct; 14(10):3436-3447. PubMed ID: 28880093
[TBL] [Abstract][Full Text] [Related]
13. Oxymorphone active uptake at the blood-brain barrier and population modeling of its pharmacokinetic-pharmacodynamic relationship.
Sadiq MW; Boström E; Keizer R; Björkman S; Hammarlund-Udenaes M
J Pharm Sci; 2013 Sep; 102(9):3320-31. PubMed ID: 23463542
[TBL] [Abstract][Full Text] [Related]
14. Effect of transporter inhibition on the distribution of cefadroxil in rat brain.
Chen X; Loryan I; Payan M; Keep RF; Smith DE; Hammarlund-Udenaes M
Fluids Barriers CNS; 2014; 11(1):25. PubMed ID: 25414790
[TBL] [Abstract][Full Text] [Related]
15. Increased brain penetration of diphenhydramine and memantine in rats with adjuvant-induced arthritis.
Kawase A; Kazaoka A; Shimada H; Iwaki M
Brain Res; 2021 Oct; 1768():147581. PubMed ID: 34280372
[TBL] [Abstract][Full Text] [Related]
16. Revisiting atenolol as a low passive permeability marker.
Chen X; Slättengren T; de Lange ECM; Smith DE; Hammarlund-Udenaes M
Fluids Barriers CNS; 2017 Oct; 14(1):30. PubMed ID: 29089037
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of pericyte involvement in small-molecular drug transport across the blood-brain barrier.
Mihajlica N; Betsholtz C; Hammarlund-Udenaes M
Eur J Pharm Sci; 2018 Sep; 122():77-84. PubMed ID: 29933077
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone.
Okura T; Hattori A; Takano Y; Sato T; Hammarlund-Udenaes M; Terasaki T; Deguchi Y
Drug Metab Dispos; 2008 Oct; 36(10):2005-13. PubMed ID: 18606742
[TBL] [Abstract][Full Text] [Related]
19. Multiple drug transporters contribute to the brain transfer of levofloxacin.
Cen Y; Shan Y; Zhao J; Xu X; Nie Z; Zhang J
CNS Neurosci Ther; 2023 Jan; 29(1):445-457. PubMed ID: 36253925
[TBL] [Abstract][Full Text] [Related]
20. Involvement of Proton-Coupled Organic Cation Antiporter in Varenicline Transport at Blood-Brain Barrier of Rats and in Human Brain Capillary Endothelial Cells.
Kurosawa T; Higuchi K; Okura T; Kobayashi K; Kusuhara H; Deguchi Y
J Pharm Sci; 2017 Sep; 106(9):2576-2582. PubMed ID: 28454746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]